BACKGROUND: Human immunodeficiency virus (HIV) infection is a risk factor for Epstein-Barr virus (EBV)-associated lymphomas. Characterizing primary infection may elucidate risk factors for malignancy. METHODS: To describe clinical and virologic manifestations of primary EBV infection among infants born to HIV-infected women, specimens were utilized from a cohort study conducted in Nairobi, Kenya. HIV and EBV viral loads were measured serially in plasma. EBV serology was performed on EBV DNA-negative infants. Monthly clinical examinations were performed by pediatricians. RESULTS: The probability of EBV infection by 1 year of age was .78 (95% CI, .67-.88) in HIV-infected and .49 (95% CI, .35-.65) in HIV-uninfected infants (P < .0001). At 2 years, probability of EBV infection was .96 (95% CI, .89-.99) in HIV-infected infants. Peak EBV loads were higher in HIV-infected versus HIV-uninfected infants (median 2.6 vs 2.1 log10 copies/mL; P < .0001). The majority of HIV-infected infants had detectable EBV DNA for >3 months (79%). Primary EBV infection was associated with cough, fever, otitis media, pneumonia, hepatomegaly, splenomegaly, and hospitalization in HIV-infected infants; conjunctivitis and rhinorrhea in HIV-uninfected infants. CONCLUSIONS: EBV infection occurs early in infants born to HIV-infected women. HIV infection was associated with more frequent and higher quantity EBV DNA detection.
BACKGROUND: Human immunodeficiency virus (HIV) infection is a risk factor for Epstein-Barr virus (EBV)-associated lymphomas. Characterizing primary infection may elucidate risk factors for malignancy. METHODS: To describe clinical and virologic manifestations of primary EBV infection among infants born to HIV-infectedwomen, specimens were utilized from a cohort study conducted in Nairobi, Kenya. HIV and EBV viral loads were measured serially in plasma. EBV serology was performed on EBV DNA-negative infants. Monthly clinical examinations were performed by pediatricians. RESULTS: The probability of EBV infection by 1 year of age was .78 (95% CI, .67-.88) in HIV-infected and .49 (95% CI, .35-.65) in HIV-uninfectedinfants (P < .0001). At 2 years, probability of EBV infection was .96 (95% CI, .89-.99) in HIV-infectedinfants. Peak EBV loads were higher in HIV-infected versus HIV-uninfectedinfants (median 2.6 vs 2.1 log10 copies/mL; P < .0001). The majority of HIV-infectedinfants had detectable EBV DNA for >3 months (79%). Primary EBV infection was associated with cough, fever, otitis media, pneumonia, hepatomegaly, splenomegaly, and hospitalization in HIV-infectedinfants; conjunctivitis and rhinorrhea in HIV-uninfectedinfants. CONCLUSIONS:EBV infection occurs early in infants born to HIV-infectedwomen. HIV infection was associated with more frequent and higher quantity EBV DNA detection.
Authors: S Emery; S Bodrug; B A Richardson; C Giachetti; M A Bott; D Panteleeff; L L Jagodzinski; N L Michael; R Nduati; J Bwayo; J K Kreiss; J Overbaugh Journal: J Clin Microbiol Date: 2000-07 Impact factor: 5.948
Authors: Elizabeth M Obimbo; Dorothy A Mbori-Ngacha; James O Ochieng; Barbra A Richardson; Phelgona A Otieno; Rose Bosire; Carey Farquhar; Julie Overbaugh; Grace C John-Stewart Journal: Pediatr Infect Dis J Date: 2004-06 Impact factor: 2.129
Authors: E Martro; M Bulterys; J A Stewart; T J Spira; M J Cannon; T D Thacher; R Bruns; P E Pellett; S C Dollard Journal: J Med Virol Date: 2004-01 Impact factor: 2.327
Authors: Brad H Pollock; Hal B Jenson; Charles T Leach; Kenneth L McClain; Robert E Hutchison; Linda Garzarella; Vijay V Joshi; Richard T Parmley; Sharon B Murphy Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye Journal: N Engl J Med Date: 2003-10-02 Impact factor: 91.245
Authors: Jinping Liu; Wei Tang; Anuradha Budhu; Marshonna Forgues; Maria O Hernandez; Julián Candia; Yujin Kim; Elise D Bowman; Stefan Ambs; Yongmei Zhao; Bao Tran; Xiaolin Wu; Christopher Koh; Pallavi Surana; T Jake Liang; Maria Guarnera; Dean Mann; Manoj Rajaure; Tim F Greten; Zhanwei Wang; Herbert Yu; Xin Wei Wang Journal: Cell Date: 2020-06-10 Impact factor: 41.582
Authors: Soren Gantt; Jackson Orem; Elizabeth M Krantz; Rhoda Ashley Morrow; Stacy Selke; Meei-Li Huang; Joshua T Schiffer; Keith R Jerome; Annet Nakaganda; Anna Wald; Corey Casper; Lawrence Corey Journal: J Infect Dis Date: 2016-02-24 Impact factor: 5.226
Authors: Rana Minab; Wei Bu; Hanh Nguyen; Abigail Wall; Anton M Sholukh; Meei-Li Huang; Michael Ortego; Elizabeth M Krantz; Michael Irvine; Corey Casper; Jackson Orem; Andrew T McGuire; Jeffrey I Cohen; Soren Gantt Journal: J Infect Dis Date: 2021-06-04 Impact factor: 5.226
Authors: Hlanai Gumbo; Bernard Chasekwa; James A Church; Robert Ntozini; Kuda Mutasa; Jean H Humphrey; Andrew J Prendergast Journal: PLoS One Date: 2014-12-18 Impact factor: 3.240